Call us Today! 201-728-8809 | | Contact | About |
   
 
 
 


Barcode Five Rights System

Use Barcode to prevent medication errors

ADERS ® is a barcode point of care, (BPOC), solution

Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.

Get The Latest Patient Safety and Drug Safety Updates from the FDA

FDA Press Releases RSS Feed

FDA approves new treatment for patients with migraine
Fri, 11 Oct 2019 14:13:06 EDT

The U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow is not indicated for the preventive treatment of migraine.

FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens
Thu, 10 Oct 2019 13:40:22 EDT

Today, FDA allowed marketing of a rapid diagnostic test (RDT) to detect Ebola virus antigens. The OraQuick Ebola Rapid Antigen Test is the first rapid diagnostic test FDA has allowed to be marketed in the U.S. for Ebola Virus Disease (EVD).

FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth
Thu, 10 Oct 2019 11:21:10 EDT

FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth

Statement on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses
Wed, 09 Oct 2019 12:45:25 EDT

Statement from Acting FDA Commissioner Ned Sharpless, M.D., on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses

FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
Wed, 09 Oct 2019 10:25:03 EDT

FDA approved Descovy in at-risk adults and adolescents for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex.

FDA approves first treatment to increase pain-free light exposure in patients with a rare disorder
Tue, 08 Oct 2019 13:21:54 EDT

FDA approves first treatment to increase pain-free light exposure in patients with a rare disorder

FDA awards two grants for natural history studies in rare diseases
Tue, 08 Oct 2019 11:04:44 EDT

FDA awards two grants for natural history studies in rare diseases

FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
Tue, 08 Oct 2019 10:31:00 EDT

FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases

FDA informs patients, providers and manufacturers about potential cybersecurity vulnerabilities for connected medical devices and health care networks that use certain communication software
Tue, 01 Oct 2019 11:03:09 EDT

FDA is informing patients, health care professionals, IT staff in health care facilities and manufacturers of a set of cybersecurity vulnerabilities, referred to as “URGENT/11,” that—if exploited by a remote attacker—may introduce risks for medical devices and hospital networks

Statement on measuring the progress being made through implementing the FDA Food Safety Modernization Act
Mon, 30 Sep 2019 13:41:33 EDT

New performance measures show progress being made in implementing the Food Safety Modernization Act

FDA and DEA warn website operators illegally selling opioids
Mon, 30 Sep 2019 11:05:20 EDT

FDA and DEA issued joint warning letters to online networks illegally marketing unapproved and misbranded versions of opioids that are potentially dangerous.

Statement on continued efforts to evaluate materials in medical devices to address potential safety questions
Mon, 30 Sep 2019 09:42:56 EDT

FDA announces next steps the agency is taking as part of its ongoing work to better evaluate the safety of specific materials used in medical devices. This includes holding our first public advisory committee meeting to convene experts and the public on this issue and providing new information on sc

FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels
Fri, 27 Sep 2019 13:39:27 EDT

FDA approves Rituxan (rituximab) injection to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children ages 2 and older in combination with steroid hormones. It is the first approved treatment for children with these rare vasculitis diseases.

FDA approves treatment for adults and children with all genotypes of hepatitis C and compensated cirrhosis that shortens duration of treatment to eight weeks
Thu, 26 Sep 2019 15:37:15 EDT

FDA expands approval of Mavyret (glecaprevir and pibrentasvir) tablets for an eight-week duration for the treatment of adults and children with hepatitis C virus genotype 1, 2, 3, 4, 5 or 6 infection and compensated cirrhosis and have not been previously treated for HCV (treatment-naïve).

Statement on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight
Thu, 26 Sep 2019 09:21:45 EDT

Statement from FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight

Remarks prepared for testimony before a U.S. House Energy and Commerce Subcommittee on FDA Regulation of Electronic Nicotine Delivery Systems and Investigation of Vaping Illnesses
Wed, 25 Sep 2019 13:06:42 EDT

Remarks from Acting FDA Commissioner Ned Sharpless, M.D. as prepared for testimony before a U.S. House Energy and Commerce Subcommittee on FDA Regulation of Electronic Nicotine Delivery Systems and Investigation of Vaping Illnesses

FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
Tue, 24 Sep 2019 18:46:54 EDT

The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc.

FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox
Tue, 24 Sep 2019 15:15:49 EDT

The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. This is the

Statement on FDA efforts to encourage patient engagement in medical device clinical investigations
Mon, 23 Sep 2019 10:38:04 EDT

FDA releases draft guidance providing our proposed recommendations for manufacturers to engage patients in multiple aspects of medical device clinical investigation design

Statement on final guidance to help advance development of novel treatments for ALS
Mon, 23 Sep 2019 10:10:04 EDT

Statement on final guidance to help advance development of novel treatments for ALS

Food and Drugs Administration--Recalls/Safety Alerts

Mical Seafood Inc Recalls Tuna Products for Possible Scombroid Poisoning
Tue, 15 Oct 2019 18:55:04 EDT

Voluntarily initiated a recall of frozen, wild-caught yellowfin tuna poke cubes, tuna loins, tuna ground meat and 6oz tuna steaks because of potentially elevated levels of histamine. Elevated levels of histamines can produce an allergic reaction called scombroid fish poisoning.

Mical Seafood Inc. Voluntarily Expands Tuna Recall for Possible Scombroid Poisoning
Tue, 15 Oct 2019 18:52:26 EDT

Mical Seafood, Inc. of Cooper City, FL, has voluntarily initiated an expanded recall of frozen, wild-caught yellowfin Tuna Loins, Tuna Poke, Tuna Steaks, Tuna Ground Meat, and Tuna Saku (products of Vietnam) due to potentially elevated levels of histamine.

Samurai, Inc. Issues Allergy Alert On Undeclared Fish In Furikake Popcorn 5oz. Package
Tue, 15 Oct 2019 18:50:04 EDT

Samurai, Inc. of Honolulu, Hawaii is conducting a voluntary recall on 16,660 packages of Furikake Popcorn, because it may contain undeclared Fish. People who have an allergy or severe sensitivity to fish run the risk of serious or life-threatening allergic reaction if they consume these products.

Frozen and Refrigerated Cookie Dough Products Recalled Due to Potential Health Risk from Allergens
Thu, 10 Oct 2019 20:36:43 EDT

California New Foods has issued a voluntary recall of frozen and refrigerated cookie dough products due to a lack of labeling that addresses the potential for the products to contain peanut and walnut allergens.

Update: Recall of Frozen Cookie Dough Products Due to Allergen Health Risk is Expanded to Include Additional Lot Codes
Thu, 10 Oct 2019 20:32:09 EDT

California New Foods has expanded its voluntary recall of frozen cookie dough products due to a lack of labeling that addresses the potential for the products to contain peanut and walnut allergens.

Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of all Sterile Compounded Drug Products Due to a Lack of Sterility Assurance
Thu, 10 Oct 2019 19:38:12 EDT

Innoveix Pharmaceuticals, Inc. is voluntarily recalling all sterile compounded drug products, within expiry, to the consumer level. The products are being recalled due to a lack of assurance of sterility. These concerns arose following a routine inspection of the pharmacy by FDA.

Fisherman’s Pride Processors Issues Recall of Shrimp Product Due to Misbranding and Undeclared Milk and Soy Allergens
Thu, 10 Oct 2019 16:59:33 EDT

Fisherman’s Pride Processors Inc. of Vernon, CA is recalling 100 bags of Schwan’s Brand “Garlic Herb Shrimp” with date code 4A924608xx-B1 due to undeclared milk and soy.

UNFI Voluntarily Recalls Arla Apetina Marinated Feta & Olives in Oil, Pitted Because of Possible Health Risk
Thu, 10 Oct 2019 14:33:05 EDT

The product requires refrigeration to ensure food safety and we have learned that some product distributed to retail customers from 2 UNFI distribution centers may have been exposed to temperatures above refrigeration during storage and/or distribution by UNFI’S customers.

Jumbo Foods Inc. Recalls Frozen & Fresh Chicken Salad Sandwiches Because of Possible Health Risk
Thu, 10 Oct 2019 08:24:12 EDT

Jumbo Foods Inc. of Mukilteo, WA has issued a voluntary recall of Tuscan Sun (TS) brand chicken salad sandwiches, because it has the potential to be contaminated with Listeria monocytogenes

Allergy Alert for Undeclared Milk & Egg In White Parkerhouse Rolls Issued by Four Whole Foods Market Stores in Midwest
Thu, 10 Oct 2019 06:21:53 EDT

Four Whole Foods Market stores in the Midwest region are voluntarily recalling White Parkerhouse Rolls because they may contain undeclared milk and egg.

Abbott Laboratories Recalls Calcilo XD® Infant Formula
Wed, 09 Oct 2019 12:06:42 EDT

Out of an abundance of caution, Abbott has voluntarily recalled a single lot of Calcilo XD® powder cans (13.2oz / 375g) with lot number 79696K80 in the United States and Canada due to an inconsistency in aroma and color in a small number of cans from this specific batch.

Blue Bell Ice Cream Recalls a Select Lot of Butter Crunch Half Gallons for Possible Foreign Object
Wed, 09 Oct 2019 11:01:45 EDT

Blue Bell Ice Cream is voluntarily recalling a select lot of half gallon Butter Crunch Ice Cream produced on a specific line on August 26, 2019 in its Sylacauga, AL plant because of the possibility the products may contain a foreign object.

ICU Medical Issues a Voluntary Nationwide Recall of Certain Lots of Plum and Sapphire Microbore Infusion Sets with Inline Filters
Tue, 08 Oct 2019 20:33:44 EDT

ICU Medical, Inc. announced a voluntary recall on 29 July 2019 of certain lots of Plum and Sapphire Microbore Infusion Sets with inline filters due to the potential for small amounts of fluid leaking out of the air vents on the inline filters. To date, ICU Medical is not aware of adverse events rela

Lipari Foods Issues Recall of Bulk Chicken Salads and Chicken Salad Sandwiches Due to Potential Contamination of Listeria Monocytogenes
Tue, 08 Oct 2019 14:25:06 EDT

Voluntary recall of Lipari Old Tyme Bulk Chicken Salad, Lipari Old Tyme Bulk Cranberry Almond Chicken Salad, Premo Chicken Salad Wedge Sandwiches, Fresh Grab Chicken Salad Wedge Sandwiches, and Premo Signature Cranberry Almond Chicken Salad on Croissant due to Listeria monocytogenes

Lipari Foods Issues Recall of Ham & Cheese Wedge Sandwiches Due to Potential Contamination of Listeria Monocytogenes
Tue, 08 Oct 2019 13:20:45 EDT

Lipari Foods has issued a voluntary recall of Premo Ham & Cheese Wedge Sandwiches and Fresh Grab Ham & Cheese Wedge Sandwiches due to potential contamination of Listeria monocytogenes

ADM Animal Nutrition Recalls MoorMan’s® ShowTec® Lamb Creep DC
Fri, 04 Oct 2019 19:51:10 EDT

ADM Animal Nutrition, a division of Archer Daniels Midland Company (NYSE: ADM), is voluntarily recalling 50-pound bags of MoorMan’s® ShowTec® Lamb Creep DC, product number 11153AE, because the product may contain high levels of copper.

The J. M. Smucker Company Issues Voluntary Recall of Specific Lots of Robin Hood® All Purpose Flour Distributed and Sold in the U.S. Only
Fri, 04 Oct 2019 16:23:10 EDT

Out of an abundance of caution, The J. M. Smucker Company today announced a voluntary recall of specific lots of Robin Hood® All Purpose Flour distributed and sold in the U.S. due to possible E. coli contamination. This recall does not impact any Robin Hood® items sold in Canada.


Coborn’s, Inc. Issues Recall of Select Chicken Salad Products Due to Possible Listeria Contamination
Fri, 04 Oct 2019 13:55:13 EDT

Coborn's, Inc. is recalling select chicken salad products, which may have been contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

Ample Hills Manufacturing, LLC Issues Allergy Alert on Undeclared Peanut in Peppermint Pattie Ice Cream
Fri, 04 Oct 2019 11:36:03 EDT

Ample Hills Manufacturing of Brooklyn, New York is recalling all half pints of Peppermint Pattie Ice Cream (lot code 19169, all time stamps with Best by Date 6/18/20) (80z) (236ml) because they may contain undeclared peanut. People who have an allergy or severe sensitivity to peanut run the risk of

Grand Strand Sandwich Company Recalls Lunch Box Chicken Salad Fresh Wedges, Lunch Box Chicken Salad Frozen Wedges, Fresh and Local Chicken Salad Croissants Due to Possible Listeria Monocytogenes Contamination
Fri, 04 Oct 2019 11:03:59 EDT

Lunch Box Chicken Salad Fresh Wedges with sell by 10/29/19 to 10/08/19, Lunch Box Chicken Salad Frozen Wedges with a julian date of , Fresh and Local Chicken Salad Croissants sell by date of 10/10/19 and 9/26/19 and due to a potential contamination of Listeria monocytogenes.

What's New: Drugs RSS Feed

Regulatory Science in Action
Tue, 15 Oct 2019 23:25:04 EDT

Developing new tools, standards, and approaches to assess drug safety, efficacy, quality, and performance

Stop - Learn - Go: Tips for Talking with Your Pharmacist to Learn How to Use Medicines Safely
Tue, 15 Oct 2019 18:20:08 EDT

Points to discuss with your pharmacist and other healthcare providers

2019 Meeting Materials, Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))
Tue, 15 Oct 2019 17:52:15 EDT

2019 Meeting Materials, Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))

Waiver for Conflicts of Interest for the October 30, 2019 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)
Tue, 15 Oct 2019 17:45:18 EDT

Waiver for Conflicts of Interest for the October 30, 2019 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)

What's New Related to Drugs
Tue, 15 Oct 2019 16:25:08 EDT

Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Warning Letters 2019
Tue, 15 Oct 2019 15:08:22 EDT

These letters are supplied by the CDER Freedom of Electronic Information Office. This page only covers Office of Prescription Drug Promotion (formerly Division of Drug Marketing, Advertising and Communications) and CDER Headquarters Warning Letters.

Research Tools and Resources
Tue, 15 Oct 2019 14:37:48 EDT

Scientific tools, databases, and information for drug developers

Work With Us
Tue, 15 Oct 2019 14:37:33 EDT

Learn about scientific careers at CDER and how to collaborate with us

What's New in Regulatory Science
Tue, 15 Oct 2019 14:25:20 EDT

A newsletter on regulatory science for CDER's stakeholders

Dr. Woodcock on Regulatory Science
Tue, 15 Oct 2019 14:20:51 EDT

Educational videos on select regulatory science topics by the Director of CDER

CDER Scientists in their Own Words
Tue, 15 Oct 2019 14:15:15 EDT

Video discussions of how current challenges in regulatory science are being met

Impact Stories
Tue, 15 Oct 2019 14:06:30 EDT

Stories illustrating how regulatory science impacts the lives and health of people


Oncologic Drugs Advisory Committee Roster
Tue, 15 Oct 2019 14:06:06 EDT

This page contains the ODAC roster, which lists the current members and the current number of vacancies for the committee.

Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee) Roster
Tue, 15 Oct 2019 13:55:07 EDT

This page contains the AMDAC roster, which lists the current members and the current number of vacancies for the committee

Drug Shortages | Additional News and Information
Tue, 15 Oct 2019 13:35:23 EDT

Drug Shortages: Additional News and Information

Dermatologic and Ophthalmic Drugs Advisory Committee Roster
Tue, 15 Oct 2019 13:30:26 EDT

This page contains the DODAC roster, which lists the current members and the current number of vacancies for the committee.

All Guidances for Drugs
Tue, 15 Oct 2019 11:30:05 EDT

Guidance documents represent the Agency's current thinking on a particular subject.

FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)
Tue, 15 Oct 2019 11:23:09 EDT

Get updates on the recalls

Glenmark Pharmaceuticals Limited - 582701 - 10/03/2019
Tue, 15 Oct 2019 09:22:31 EDT

CGMP/Finished Pharmaceuticals/Adulterated

The Skin Atelier, Inc. d.b.a. Skinprint - 582512 - 10/01/2019
Tue, 15 Oct 2019 09:20:49 EDT

CGMP/Finished Pharmaceuticals/Adulterated

Whats New Vaccines Blood Biologics RSS Feed

Wilate
Wed, 16 Oct 2019 06:35:59 EDT

Product approval information is indicated for children and adults with von Willebrand disease for on-demand treatment and control of bleeding episodes and perioperative management of bleeding.

Biologics PREA Reviews and Labeling Changes
Wed, 16 Oct 2019 06:20:38 EDT

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

Allergenics
Tue, 15 Oct 2019 16:55:19 EDT

Lists three types of allergenic products licensed for use: allergen extracts, allergen patch tests, and antigen skin tests. Allergen extracts are used for the diagnosis and/or treatment of allergic diseases such as allergic rhinitis ("hay fever"), allergic sinusitis, allergic conjunctivitis, bee venom allergy and food allergy. Allergen patch tests are diagnostic tests applied to the surface of the skin. Antigen skin tests are diagnostic tests injected into the skin to aid in the diagnosis of infection with certain pathogens.

What’s New for Biologics
Tue, 15 Oct 2019 16:45:11 EDT

Latest news from the Center for Biologics Evaluation and Research

Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Tue, 15 Oct 2019 16:05:22 EDT

Indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7

November 7, 2017: Vaccines and Related Biological Products Advisory Committee Meeting Announcement - 11/07/2017 - 11/07/2017
Tue, 15 Oct 2019 14:52:43 EDT

This is the Meeting Announcement for the November 7, 2017, Vaccines and Related Biological Products Advisory Committee Meeting

Westlake IVF, LLC - 590113 - 09/30/2019
Tue, 15 Oct 2019 09:20:50 EDT

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

Rare Pediatric Disease Priority Review Vouchers
Tue, 15 Oct 2019 06:55:03 EDT

Draft guidance for industry on rare pediatric disease priority review vouchers, revised July 2019

Resources for You (Biologics)
Fri, 11 Oct 2019 15:56:35 EDT

Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins.

Consumer Updates
Fri, 11 Oct 2019 15:56:12 EDT

Get timely, reliable, health and safety information about food, drugs, medical devices, vaccines, pet food, pet medicine and more.

Perspectives on In Vitro Diagnostic Devices Regulated by the Office of Blood Research and Review; Public Workshop - 07/15/2019 - 07/16/2019
Fri, 11 Oct 2019 15:40:24 EDT

The purpose of this workshop is to provide an overview of key elements of regulatory submissions for these devices, and to facilitate education and communication between manufacturers and sponsors of these devices and the divisions in CBER that regulate them.

Regenerative Medicine Advanced Therapy Designation
Fri, 11 Oct 2019 14:50:31 EDT

Eligibility requirements for a regenerative medicine advanced therapy (RMAT) designation. Information on when and where to submit the request is also provided.

Administrative Guidances
Fri, 11 Oct 2019 10:50:43 EDT

This page lists Administrative Guidance documents.

Recently Issued Guidance Documents
Fri, 11 Oct 2019 10:50:04 EDT

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

Section 8200: Investigational New Drugs (INDs)
Thu, 10 Oct 2019 15:06:35 EDT

This is the SOPP Section 8200: Investigational New Drugs (INDs) main page.

Emergency Use Authorization
Thu, 10 Oct 2019 13:51:42 EDT

The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against CBRN threats by facilitating the availability and use of MCMs needed during public health emergencies

Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review
Thu, 10 Oct 2019 10:50:38 EDT

Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review, Guidance for Industry, Technical Specifications Document, OVRR, CBER, Biologics, Application Submissions Guidance, Vaccine and Related Biological Product Guidance, Study Data Standards Resources Guidance

Innovation and Regulatory Science
Thu, 10 Oct 2019 08:36:35 EDT

Innovation and Regulatory Science

Influenza candidate vaccine viruses improved by amino acid substitution in hemagglutinin
Thu, 10 Oct 2019 07:49:25 EDT

Scientists at the U.S. Food and Drug Administration (FDA) developed two candidate vaccine viruses (CVVs) that may be used as the starting material for production of inactivated influenza vaccines. These CVVs protected laboratory animals against a highly pathogenic strain of Influenza A (H7N9), a pot

MedWatch: The FDA Safety Information and Adverse Event Reporting Program
Wed, 09 Oct 2019 23:40:08 EDT

MedWatch home page


Here are some headlines supporting the benefits of a system like ADERS ®:



See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.


More about ADERS ®


Products

Services

News Letter

Free Stuff From PCS

About PCS

Our About Page
Our Contact Page
Terms of Use
Our Privacy Policy
Full Site Map
Corporate Headquarters

Practical Compliance Solutions
One Orient Way - Suite F156 Rutherford, NJ 07070
Phone: 201-728-8809


40.827731 N 74.101029 W
Connect With Us


Share




Barcode Tracking Systems
© 2002 - 2019 - Copyright Practical Compliance Solutions - All rights reserved